Cart
sales@molnova.com
PythiDC
CAS No. 1821370-71-1
PythiDC( —— )
Catalog No. M23828 CAS No. 1821370-71-1
PythiDC is a selective collagen prolyl 4-hydroxylase inhibitor, neither causing general toxicity nor disrupting iron homeostasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 102 | In Stock |
|
| 50MG | 161 | In Stock |
|
| 100MG | 239 | In Stock |
|
| 200MG | 347 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePythiDC
-
NoteResearch use only, not for human use.
-
Brief DescriptionPythiDC is a selective collagen prolyl 4-hydroxylase inhibitor, neither causing general toxicity nor disrupting iron homeostasis.
-
DescriptionPythiDC is a selective collagen prolyl 4-hydroxylase inhibitor, neither causing general toxicity nor disrupting iron homeostasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorcollagen prolyl 4-hydroxylase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1821370-71-1
-
Formula Weight250.22
-
Molecular FormulaC10H6N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:2.5 mM
-
SMILESC1=CC(=NC=C1C(=O)O)C2=NC=C(S2)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
FEN1 Inhibitor C2
FEN1-IN-4 is an inhibitor of human flap endonuclease-1 (hFEN1)FEN1 Inhibitor C2 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a, both frequently mutated in colorectal cancers.?
-
IGF-I (24-41) TFA
IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth Factor I (IGF-I).
-
Felzartamab
Felzartamab(MOR-202) is a human-targeted monoclonal antibody to CD38 for the study of multiple myeloma and advanced antibody-mediated rejection of allogeneic kidney transplants.
